Clincosm LogoSign in Get a demo

Leiomyosarcoma

Showing 26 - 50 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Differential Diagnosis of Uterine Leiomyomas and

Recruiting
  • Leiomyoma
  • Leiomyosarcoma
  • Biopsy and peripheral blood collection
  • Cartagena, Murcia, Spain
  • +3 more
Sep 2, 2021

Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)

Terminated
Has Results
  • Solid Tumor
  • +8 more
  • Houston, Texas
  • +1 more
Aug 4, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

Active, not recruiting
  • Sarcoma
  • +10 more
  • Hypofractionated radiotherapy
  • Hyperthermia
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021

Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

Unknown status
  • Sarcoma
  • +16 more
  • Sequential chemotherapy - 3 courses of AI
  • Hypofractionated radiotherapy
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021

Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)

Terminated
Has Results
  • Leiomyosarcoma
  • +2 more
  • Vorinostat Oral Capsule
  • Graz, Austria
    Medical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020

Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -

Completed
Has Results
  • Hodgkin Disease
  • +3 more
  • LMP1/2 CTLs (ALCI - Group A)
  • +8 more
  • Houston, Texas
  • +1 more
May 26, 2020

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoproliferative Disorder Trial in Houston (LMP specific T cells)

Completed
  • Hodgkin Lymphoma
  • +5 more
  • LMP specific T cells
  • Houston, Texas
  • +1 more
Feb 5, 2020

Leiomyosarcoma Trial in France (pazopanib + gemcitabine)

Completed
  • Leiomyosarcoma
  • pazopanib + gemcitabine
  • Bordeaux, France
  • +16 more
Jan 29, 2020

Patient Reported Outcome Measures (PROMs) With Trabectedin

Unknown status
  • Sarcoma
  • +2 more
    • Leeds, West Yorkshire, United Kingdom
      Leeds Teaching Hospitals NHS Trust
    May 20, 2019

    Leiomyosarcoma, Liposarcoma, Synovial Sarcoma Trial in Italy (Trabectedin discontinuation, Trabectedin continuation)

    Withdrawn
    • Leiomyosarcoma
    • +2 more
    • Trabectedin discontinuation
    • Trabectedin continuation
    • Alessandria, AL, Italy
    • +14 more
    May 9, 2019

    Leiomyosarcoma Trial (Trabectedin, Doxorubicin, Olaratumab)

    Withdrawn
    • Leiomyosarcoma
    • (no location specified)
    Mar 14, 2019

    Leiomyosarcoma, Uterine Tumor Trial in Houston (Letrozole)

    Terminated
    Has Results
    • Leiomyosarcoma
    • Uterine Neoplasm
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 23, 2018

    Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Rhabdomyosarcoma, Leiomyosarcoma Trial in Worldwide (IMC-A12

    Completed
    Has Results
    • Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET)
    • +4 more
    • IMC-A12 (cixutumumab)
    • Aurora, Colorado
    • +21 more
    Jun 18, 2018

    Detection of Circulating Tumor Cells in Patients With Sarcomas

    Unknown status
    • Leiomyosarcoma
    • +3 more
      • Sao Paulo, SP, Brazil
        ACCamargo Cancer Center
      Jun 29, 2018

      Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor Trial in United States (Pazopanib 400 mg QD - Gemcitabine and

      Terminated
      Has Results
      • Sarcoma
      • +4 more
      • Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination
      • Los Angeles, California
      • +3 more
      Dec 11, 2017

      Leiomyosarcoma Trial in Italy (gemcitabine + docetaxel, trabectedin)

      Completed
      • Leiomyosarcoma
      • Aviano, Pordenone, Italy
      • +33 more
      Dec 5, 2017

      Soft Tissue Sarcoma, Fibrous Histiocytoma, Liposarcoma Trial in Boston (drug, radiation, procedure)

      Completed
      Has Results
      • Soft Tissue Sarcoma
      • +5 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 14, 2017

      Leiomyosarcoma Trial in Boston (letrozole)

      Completed
      Has Results
      • Leiomyosarcoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 22, 2017

      Concordance Between Gynaecologic Sonography Amd Pelvic MRI for

      Unknown status
      • Leiomyoma
      • Leiomyosarcoma
      • Pre-surgical diagnosis of uterine malignant tumors
      • (no location specified)
      Oct 18, 2016

      Sarcoma, Leiomyosarcoma, Malignant Fibrous Trial in New York (gemcitabine, docetaxel, bevacizumab)

      Completed
      Has Results
      • Sarcoma
      • +4 more
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Dec 21, 2015

      Sarcoma, Synovial Sarcoma, Leiomyosarcoma Trial in New York (Sorafenib and Dacarbazine)

      Completed
      Has Results
      • Sarcoma
      • +3 more
      • Sorafenib and Dacarbazine
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Oct 19, 2015

      Leiomyosarcoma, Liposarcoma Trial in Mannheim (Gemcitabine + Trabectedin)

      Completed
      • Leiomyosarcoma
      • Liposarcoma
      • Gemcitabine + Trabectedin
      • Mannheim, Germany
        Mannheim University Medical Center
      Dec 15, 2014

      Leiomyosarcoma, Uterine Tumor Trial in United States (gemcitabine, docetaxel, doxorubicin)

      Completed
      Has Results
      • Leiomyosarcoma
      • Uterine Neoplasm
      • gemcitabine, docetaxel, doxorubicin
      • Washington, District of Columbia
      • +11 more
      Nov 23, 2014

      Osteosarcoma, Ewing Sarcoma Family Tumors, Malignant Fibrous Histiocytoma Trial in United States (REOLYSIN®)

      Completed
      • Osteosarcoma
      • +5 more
      • REOLYSIN®
      • Ann Arbor, Michigan
      • +3 more
      Sep 30, 2014